Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
194
Historia
147
Política y gobierno
74
Impuestos
68
Impuestos sobre la renta
41
Derecho fiscal
26
Derecho civil
25
Industria de la construcción
16
Condiciones económicas
15
Seguridad social
15
Derecho constitucional
13
Democracia
12
Derecho laboral
12
Condiciones sociales
11
México
11
Elecciones
10
Legislación
9
Partidos políticos
9
Regulación del comercio exterior
9
Colonias
8
Derecho administrativo
8
Educación
8
Historia constitucional
8
Impuesto sobre el valor agregado
8
Agricultura
7
Aranceles de aduana
7
Causas
7
Derecho
7
Función pública
7
Impuesto al valor agregado
7
-
59381por Bickham, Kara, Kivitz, Alan J., Mehta, Anish, Frontera, Nancy, Shah, Sandhya, Stryszak, Paul, Popmihajlov, Zoran, Peloso, Paul M.“…BACKGROUND: Treatment with non-steroidal anti-inflammatory drugs (NSAID) is a common component of treatment regimens for rheumatoid arthritis (RA). Etoricoxib is a COX-2 selective NSAID that has demonstrated efficacy in the treatment of RA at a dose of 90 mg. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59382por Neal, Joel W., Dahlberg, Suzanne E., Wakelee, Heather A., Aisner, Seena C., Bowden, Michaela, Huang, Ying, Carbone, David P., Gerstner, Gregory J., Lerner, Rachel E., Rubin, Jerome L., Owonikoko, Taofeek K., Stella, Philip J., Steen, Preston D., Khalid, Ahmed Ali, Ramalingam, Suresh S.“…Despite its modest sample size, this trial identified signals of clinically meaningful efficacy superior to that of erlotinib alone, and additional toxicity that was generally manageable. Cabozantinib-based regimens are promising for further investigation in this patient population.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59383por von Rundstedt, Friedrich-Carl, Mata, Douglas A., Kryvenko, Oleksandr N., Shah, Anup A., Jhun, Iny, Lerner, Seth P.“…Of the 49 patients who did receive NAC, 43 (87.8%) received cisplatin-based and six (12.2%) received carboplatin-based regimens. Applying the MDACC model, we categorized 41 (83.7%) patients as high risk prior to NAC treatment. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59384por Abreha, Tesfay, Hwang, Jimee, Thriemer, Kamala, Tadesse, Yehualashet, Girma, Samuel, Melaku, Zenebe, Assef, Ashenafi, Kassa, Moges, Chatfield, Mark D., Landman, Keren Z., Chenet, Stella M., Lucchi, Naomi W., Udhayakumar, Venkatachalam, Zhou, Zhiyong, Shi, Ya Ping, Kachur, S. Patrick, Jima, Daddi, Kebede, Amha, Solomon, Hiwot, Mekasha, Addis, Alemayehu, Bereket Hailegiorgis, Malone, Joseph L., Dissanayake, Gunewardena, Teka, Hiwot, Auburn, Sarah, von Seidlein, Lorenz, Price, Ric N.“…To compare the efficacy and safety of primaquine regimens for radical cure, we undertook a randomized controlled trial in Ethiopia. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59385por Withee, Eric D., Tippens, Kimberly M., Dehen, Regina, Tibbitts, Deanne, Hanes, Douglas, Zwickey, Heather“…BACKGROUND: Oxidative stress and muscle damage occur during exhaustive bouts of exercise, and many runners report pain and soreness as major influences on changes or breaks in training regimens, creating a barrier to training persistence. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59386por Rubino, Christopher M, Smith, Larry R, Mammen, Mammen P, Hopkins, Andrew M, Lakota, Elizabeth A, Sullivan, Sean M“…Comparisons of the simulated VL-2397 tAUC(0-24):MIC on Day 1 in humans receiving daily dosing regimens of 300 mg, 600 mg, and 900 mg of VL-2397 to the 2-log target (figure) suggested that a dose of 600 mg Q24 would provide robust (99.9%) PK-PD target attainment up to an A. fumigatus MIC of 2 µg/mL. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59387por Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, Dahle, Jostein, Martinsen, Anne C. T., Holte, Harald, Kolstad, Arne“…All patients were pre-treated with different regimens of rituximab. The patients received either 10, 15, or 20 MBq (177)Lu-lilotomab satetraxetan per kg body weight. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59388por Kebriaei, Razieh, Rice, Seth, Singh, Kavindra, Stamper, Kyle, Dinh, An, Rios, Rafael, Diaz, Lorena, Murray, Barbara, Munita, Jose M, Tran, Truc T, Arias, Cesar, Rybak, Michael J“…RESULTS: DAP alone was not bactericidal and high-level DAP resistance was observed (MIC increase from 16 to 256 µg/mL) for all DAP alone regimens. Combination of DAP+AMP offered a significant reduction in log(10)CFU/g amounts (up to 7 log(10) CFU/g and to detection limits) in 24 hours in DAP10+AMP model with no further emergence of DAP resistance. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59389por Irgens, Ingebjørg, Hoff, Jana M., Sørli, Hilde, Haugland, Hanne, Stanghelle, Johan K., Rekand, Tiina“…In the second part we will compare two different treatment regimens of PU through a randomized controlled pilot trial (RCT) where we will compare outpatient SCI follow-up in a hospital versus outpatient follow-up from the patient’s home, using telemedicine (teleSCI) interventions. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59390por BARON, Dominique, FLIN, Christian, PORTERIE, Jérôme, DESPAUX, Jacques, VINCENT, Patrice“…Sin embargo, aún existen dudas sobre la eficacia de estas inyecciones únicas, en comparación con los regímenes de inyecciones múltiples. MÉTODOS: Se realizó un estudio multicéntrico, abierto, prospectivo, post-mercado (ART-ONE 75) con el producto de inyección única ARTHRUM 2,5% (3 ml, 75 mg AH), en 214 pacientes que sufrían de AR. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59391por Mateo‐Urdiales, Alberto, Johnson, Samuel, Smith, Rhodine, Nachega, Jean B, Eshun‐Wilson, Ingrid“…It is uncertain whether rapid ART has an effect on modification of ART treatment regimens as data are lacking (RR 7.89, 95% CI 0.76 to 81.74; 977 participants, 2 studies; very low‐certainty evidence). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59392por Inch, Jacqueline, Notman, Frances, Bond, Christine M., Alldred, David P., Arthur, Antony, Blyth, Annie, Daffu-O’Reilly, Amrit, Ford, Joanna, Hughes, Carmel M., Maskrey, Vivienne, Millar, Anna, Myint, Phyo K., Poland, Fiona M., Shepstone, Lee, Zermansky, Arnold, Holland, Richard, Wright, David“…BACKGROUND: Residents in care homes are often very frail, have complex medicine regimens and are at high risk of adverse drug events. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59393por Milanović, Zoran, Pantelić, Saša, Čović, Nedim, Sporiš, Goran, Mohr, Magni, Krustrup, Peter“…Additionally, recreational football is efficient and effective as Zumba and continuous running exercise regimens with highlighted social, motivational and competitive components.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59394por Zheng, Qiyan, Yang, Huisheng, Liu, Weijing, Sun, Weiwei, Zhao, Qing, Zhang, Xiaoxiao, Jin, Huanan, Sun, Luying“…The network meta-analysis results showed that most regimens, except for leflunomide (LEF), mizoribine (MZB) and steroids (STE), showed significantly higher probabilities of total remission (TR) when compared with non-immunosuppressive therapies (the control group), with risk ratios (RRs) of 2.71 (95% CI) 1.81 to 4.06)for tacrolimus+tripterygium wilfordii (TAC+TW), 2.16 (1.27 to 3.69) foradrenocorticotropic hormone, 2.02 (1.64 to 2.49) for TAC, 2.03 (1.13 to3.64) for azathioprine (AZA), 1.91 (1.46 to 2.50) for cyclosporine (CsA), 1.86 (1.44 to2.42) for mycophenolate mofetil (MMF), 1.85 (1.52 to 2.25) for cyclophosphamide (CTX),1.81 (1.10 to 2.98) for rituximab (RIT), 1.80 (1.38 to 2.33) for TW, 1.72 (1.35 to 2.19) for chlorambucil. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59395por Daher, André, Aljayyoussi, Ghait, Pereira, Dhelio, Lacerda, Marcus V. G., Alexandre, Márcia A. A., Nascimento, Cristiana T., Alves, Júlio Castro, da Fonseca, Laís Bastos, da Silva, Diego Medeiros Dias, Pinto, Douglas Pereira, Rodrigues, Danielle Fonseca, Silvino, Ana Carolina Rios, de Sousa, Taís Nóbrega, de Brito, Cristiana Ferreira Alves, ter Kuile, Feiko O., Lalloo, David G.“…Higher CQ AUCs were associated with reduced falls in haemoglobin by day 14 (Coef − 0.02, − 0.005; − 0.03, p = 0.01). All regimens were well tolerated. CONCLUSION: Genotyping of P. vivax showed that activation of related (homologous) hypnozoites was the most frequent cause of recurrence. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59396por Penrose, Harrison Michael, Nakhoul, Hani, Ungerleider, Nathan, Flemington, Erik, Savkovic, Suzana“…These data suggest particular alterations in immune profiles and molecular pathways could play a role in non-response to biologic therapy, highlighting a future direction for personalized treatment regimens that could lead to more targeted use of existing therapies and more favorable patient health outcomes.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59397por Zhang, Dong-Xing, Kang, Yuan-Huan, Zhan, Sheng, Zhao, Ze-Lin, Jin, Sheng-Nan, Chen, Chong, Zhang, Lei, Shen, Jin-Yu, Wang, Chun-Feng, Wang, Gui-Qin, Shan, Xiao-Feng, Qian, Ai-Dong“…The present data suggest that probiotic B. velezensis act as a potential gut-targeted therapy regimens to protecting fish from pathogenic bacteria infection. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59398Publicado 2020“…No standardized treatment regimens currently exist for this rare tumor. The mainstay of treatment for early-stage disease is curative surgical resection, whereas multimodality treatment (surgery, chemotherapy, radiotherapy) has been adopted in advanced or metastatic diseases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59399por Smith, Zachary K, Holland, Ben P, Word, Alyssa B, Crawford, Grant I, Nichols, Wade N, Nuttelman, Brandon L, Streeter, Marshall N, Hutcheson, John P, Johnson, Bradley J“…Although feedlot growth performance and HCW did not differ between the implant regimens tested, increasing DOF resulted in decreased live growth performance while increasing the proportion of USDA prime carcasses and HCW.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59400por Shariff, Afreen Idris, Qamar, Ali, Rivera, Jonathan Velez, Mozingo, Lauren Kaye, Thacker, Connie, Rushing, Christel, Jung, Sinho, Salama, April Kelly, D’Alessio, David A“…Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA, Sept 2017…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto